As shown in Figure 4, the five-miRNA panel enabled identifying 33 CRC patients (70.21% sensitivity; cut-off = 0.5132), while CEA levels only enabled identifying 21 CRC patients (44.68% sensitivity; cut-off = 5 ng/mL). The gene discussed is CEACAM5; the disease is colorectal carcinoma.